Sign in to continue:

Friday, April 10th, 2026

Quantum Healthcare Limited Receives Auditor Disclaimer of Opinion for FY2025 Due to Going Concern and Legal Liabilities; No Dividend Declared

Quantum Healthcare Limited: FY2025 Financial Analysis and Investor Outlook

Quantum Healthcare Limited, listed on the Singapore Exchange (Catalist), recently released its audited financial statements for the year ended 31 December 2025. The report was accompanied by a disclaimer of opinion from its independent auditor, Forvis Mazars LLP, citing significant uncertainties regarding both its going concern status and the completeness of legal liabilities. This analysis summarizes the key findings, financial performance, and material risks based strictly on the company’s reported data.

Key Financial Metrics

  • Net Loss: S\$2,913,000 for FY2025
  • Total Comprehensive Loss: S\$2,907,000 for FY2025
  • Current Assets vs. Liabilities: Current liabilities exceeded current assets by S\$4,323,000 as at 31 December 2025
  • Shareholders’ Equity: Deficit of S\$1,053,000 as at 31 December 2025
  • Cash and Cash Equivalents: S\$2,708,000 as at 31 December 2025

Year-over-Year Financial Performance Table

Metric FY2025 FY2024 YoY Change
Net Loss S\$2,913,000 Not disclosed N/A
Total Comprehensive Loss S\$2,907,000 Not disclosed N/A
Current Assets – Current Liabilities (S\$4,323,000) Not disclosed N/A
Shareholders’ Equity (S\$1,053,000) Not disclosed N/A
Dividends Not disclosed Not disclosed N/A

Material Risks and Auditor’s Disclaimer

  • Going Concern Doubts: The auditor was unable to obtain sufficient evidence about the appropriateness of the going concern assumption due to recurring losses, negative working capital, and a deficit in shareholders’ equity. Should the going concern assumption be inappropriate, further adjustments to asset values and liabilities may be required.
  • Legal Liabilities: The Group has accrued S\$983,000 in legal claims and S\$2,939,000 in legal fees as at 31 December 2025. The auditor could not verify these figures due to the lack of written confirmation from US legal counsel and the inability to perform alternative procedures. There remains uncertainty as to the completeness and accuracy of these legal liabilities.
  • Disclaimer of Opinion: The auditor issued a disclaimer of opinion for both FY2024 and FY2025, indicating an inability to provide assurance over the company’s financial statements.

Management’s Basis for Going Concern

Despite the adverse conditions, management believes the going concern basis remains appropriate based on:

  • Cash and cash equivalents of S\$2,708,000 as at year-end
  • Expectation that major legal liabilities will not require payout during the forward-looking 16-month period
  • Assumption that certain shareholder loans will not need to be repaid within the forecast period
  • Anticipated positive cash inflow from the Group’s healthcare (primarily dental) business
  • Planned cost-cutting measures and ongoing exploration of fundraising or strategic business initiatives

Legal and Operational Uncertainties

  • The Group has been involved in legal proceedings since 2021, with a request for dismissal filed by the claimant in 2024. However, the precise quantum of potential claims and legal fees remains unconfirmed, posing a significant uncertainty to the Group’s financial position.
  • No evidence of asset revaluation, share buybacks, placements, or director remuneration was disclosed in the provided report.

Dividends

There was no disclosure of proposed dividends for FY2025 or the prior year.

Forecasted Events and Management Outlook

Management expects the Group to have sufficient cash resources for the foreseeable future, contingent on the assumptions that certain liabilities will not require payment and that positive cash flows from healthcare operations will materialize. The company also intends to implement cost-saving measures and pursue strategic initiatives and fundraising if needed.

Conclusion and Investment Recommendations

Quantum Healthcare Limited currently faces significant financial and operational uncertainties. The continued disclaimer of opinion by the auditor for two consecutive years, unresolved legal liabilities, negative working capital, and an accumulated deficit all point to a weak financial position. Management maintains a cautiously optimistic outlook, but this is heavily reliant on assumptions that may not materialize.

  • If you are currently holding the stock: Extreme caution is warranted. Consider reviewing your position and risk tolerance. Unless you have a high risk appetite and strong conviction in management’s ability to turn around operations and resolve legal issues, it may be prudent to reduce exposure or exit your position.
  • If you are not holding the stock: It is advisable to stay on the sidelines until there is clear evidence of financial stabilization, resolution of legal uncertainties, and the restoration of an unqualified audit opinion. The risk profile remains high, and potential rewards are uncertain.

Disclaimer: This analysis is based strictly on the information disclosed in the FY2025 financial report of Quantum Healthcare Limited. No forward-looking projections or external data have been incorporated. Investment decisions should be made with consideration of your personal circumstances and in consultation with a licensed financial advisor.

View Quantum Health Historical chart here



Singtel Reports Strong Q2 FY2025 Results: EBITDA Up 9%, Underlying Net Profit Rises 6.1%

Singtel Financial Report Analysis: Net Profit Declined by 42...

MPACT Q1 FY25/26 Results: DPU, Financial Performance, and Market Outlook

Mapletree Pan Asia Commercial Trust (MPACT) Q1 FY25/26 Analy...

   Ad